NBRV

Nabriva Therapeutics plc Ordinary Shares Ireland

Delisted

NBRV was delisted on the 31st of July, 2023.

34 hedge funds and large institutions have $2.41M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

33% less capital invested

Capital invested by funds: $3.58M → $2.41M (-$1.17M)

50% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 8

Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$275K
Puts
$150K
Net Calls
Net Calls Change

Top Buyers

1 +$214K
2 +$213K
3 +$152K
4
VF
Virtu Financial
New York
+$125K
5
Jane Street
Jane Street
New York
+$19K

Top Sellers

1 -$118K
2 -$40K
3 -$32K
4
Citadel Advisors
Citadel Advisors
Florida
-$30.7K
5
Osaic Holdings
Osaic Holdings
Arizona
-$25.5K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$805K
2
$282K
3
$272K
4
$255K
5
$214K
6
$125K
7
$114K
8
$51K
9
$40K
10
$34K
11
$27K
12
$25K
13
$25K
14
$23K
15
$19K
16
$14K
17
$13K
18
$13K
19
$12K
20
$10K
21
$8K
22
$8K
23
$6K
24
$6K
25
$3K